Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study-Reference-Cited by-同舟云学术

Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study

Published:2021-11-15 Issue: Volume: Page:
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Roh Eun,Hwang Soon Young,Yoo Hye Jin,Baik Sei Hyun,Lee Jin-Hee,Son Sang Joon,Kim Hyeon Ju,Park Yong Soon,Lee Sam-Gyu,Cho Be Long,Jang Hak Chul,Kim Bong Jo,Kim Miji,Won Chang Won,Choi Kyung Mook^ORCID

Funder

korea national institute of health

ministry of education

korea university medicine

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-021-10258-8.pdf

Reference31 articles.

1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686–690

2. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16:21

3. Roh E, Choi KM. Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol (Lausanne). 2020;11:332

4. Kim D, Wijarnpreecha K, Sandhu KK, Cholankeril G, Ahmed A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41(8):1832–1840

5. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014;59:1772–1778

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis;Clinical Nutrition;2024-09

2. Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population;Annals of Medicine;2024-08-12

3. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both;World Journal of Hepatology;2024-06-27

4. The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review;Journal of the ASEAN Federation of Endocrine Societies;2024-05-25

5. Metabolic-associated fatty liver disease and sarcopenia: A double whammy;World Journal of Hepatology;2024-02-27